-
admin
Posts
Korea Zinc Announces AGM Results, with the Current Management Retaining Control of the Board with Overwhelming Shareholder Support
SEOUL, South Korea, March 28, 2025 /PRNewswire/ — Korea Zinc (KRX:010130) announced on March 28 that it has successfully concluded its annual general meeting (AGM), with...
ZGC Forum highlights cutting-edge technology
BEIJING, March 28, 2025 /PRNewswire/ — A news report from China Daily: Advanced technology and top scientific achievements are in the spotlight at the 2025...
So-Young Reports Unaudited Fourth Quarter and Fiscal Year 2024 Financial Results
BEIJING, March 28, 2025 /PRNewswire/ — So-Young International Inc. (Nasdaq: SY) (“So-Young” or the “Company”), the leading aesthetic treatment platform in China connecting consumers with...
Cheche Group Reports Fourth Quarter and Full Year 2024 Unaudited Financial Results
BEIJING, March 28, 2025 /PRNewswire/ — Cheche Group Inc. (NASDAQ: CCG) (“Cheche”, “the Company” or “we”), China’s leading auto insurance technology platform, today announced its...
LONGi and Raystech Presented at the 2025 Solar & Storage Live Exhibition
BRISBANE, Australia, March 28, 2025 /PRNewswire/ — LONGi has partnered with Raystech to make a significant appearance at the Solar & Storage Live exhibition, held...
VitalHub Reports Fourth Quarter and Annual 2024 Results
Annual Recurring Revenue (ARR)⁽¹⁻²⁾ up 59% YoY to $71.1 millionTotal Revenue up 51% YoY to $20.6 millionAdjusted EBITDA ⁽²⁾ up 27% YoY to $5.0 million...
Spectral AI Announces 2024 Fourth Quarter and Full Year Financial Results
2024 Research & Development Revenue of $30 Million Successful Results from the US Burn Validation Study On Track for Regulatory Submission in US for DeepView™ System...
Beta Bionics Announces Board Appointment of Gerard Michel
IRVINE, Calif., March 27, 2025 (GLOBE NEWSWIRE) — Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today...
Annovis Bio, Inc. Receives Continued Listing Standard Notice From the NYSE
MALVERN, Pa., March 27, 2025 (GLOBE NEWSWIRE) — Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative...
Tilray Brands, Inc. to Announce Third Quarter Fiscal 2025 Financial Results on April 8, 2025
NEW YORK and LEAMINGTON, Ontario, March 27, 2025 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle...
